Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Volavka

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
International Journal of Clinical Practice|April 26, 2018
Very long-term outcome of schizophreniaJan Volavka, Jan Vevera
Evidence-Based Mental Health|December 18, 2013
Review: 15 antipsychotic drugs are more effective than placebo for the treatment of schizophrenia, but vary in their tolerabilityLeslie Citrome, Jan Volavka
Harvard Review of Psychiatry|August 31, 2002
Optimal dosing of atypical antipsychotics in adults: a review of the current evidenceLeslie Citrome, Jan Volavka
The Journal of Clinical Psychiatry|August 10, 2005
Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statementLeslie Citrome, Jan Volavka
The Journal of Clinical Psychiatry|March 26, 2009
All antipsychotics are equal, but some are more equal than othersJan Volavka, Leslie Citrome
Expert Review of Neurotherapeutics|October 9, 2009
Atypical antipsychotics: revolutionary or incremental advance?Leslie Citrome, Jan Volavka
CNS Drugs|December 3, 2011
Pharmacological management of acute and persistent aggression in forensic psychiatry settingsLeslie Citrome, Jan Volavka
Harvard Review of Psychiatry|January 8, 2021
Specific Anti-hostility Effects of Atypical Antipsychotics in Persons with Schizophrenia: From Clozapine to CariprazineLeslie Citrome, Jan Volavka
CNS Spectrums|February 28, 2014
The psychopharmacology of violence: making sensible decisionsLeslie Citrome, Jan Volavka
Diabetes Care|July 28, 2004
Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statementLeslie Citrome, Jan Volavka
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
International Journal of Clinical Practice|April 26, 2018
Very long-term outcome of schizophreniaJan Volavka, Jan Vevera
Evidence-Based Mental Health|December 18, 2013
Review: 15 antipsychotic drugs are more effective than placebo for the treatment of schizophrenia, but vary in their tolerabilityLeslie Citrome, Jan Volavka
Harvard Review of Psychiatry|August 31, 2002
Optimal dosing of atypical antipsychotics in adults: a review of the current evidenceLeslie Citrome, Jan Volavka
The Journal of Clinical Psychiatry|August 10, 2005
Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statementLeslie Citrome, Jan Volavka
The Journal of Clinical Psychiatry|March 26, 2009
All antipsychotics are equal, but some are more equal than othersJan Volavka, Leslie Citrome
Expert Review of Neurotherapeutics|October 9, 2009
Atypical antipsychotics: revolutionary or incremental advance?Leslie Citrome, Jan Volavka
CNS Drugs|December 3, 2011
Pharmacological management of acute and persistent aggression in forensic psychiatry settingsLeslie Citrome, Jan Volavka
Harvard Review of Psychiatry|January 8, 2021
Specific Anti-hostility Effects of Atypical Antipsychotics in Persons with Schizophrenia: From Clozapine to CariprazineLeslie Citrome, Jan Volavka
CNS Spectrums|February 28, 2014
The psychopharmacology of violence: making sensible decisionsLeslie Citrome, Jan Volavka
Diabetes Care|July 28, 2004
Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statementLeslie Citrome, Jan Volavka
Pageof 10